Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death

Abstract

Background Sorafenib (Sor) is the only approved multikinase inhibitor indicated for the treatment of HCC. Previous studies have shown that amygdalin (Amy) possesses anticancer activities against several cancer cell lines; we suggested that these compounds might disrupt AMPK/mTOR and BCL-2. Therefore, the current study used integrated in vitro and in silico approaches to figure out Amy and Sor’s possible synergistic activity in targeting AMPK/mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death in HepG2 cells. Results Notably, Amy demonstrated exceptional cytotoxic selectivity against HepG2 cells in comparison to normal WI-38 cells (IC50 = 5.21 mg/ml; 141.25 mg/ml), respectively. In contrast, WI-38 cells were far more sensitive to the toxicity of Sor. A substantial synergistic interaction between Amy and Sor was observed (CI50 = 0.56), which was connected to cell cycle arrest at the S and G2/M stages and increased apoptosis and potential necroptosis. Amy and Sor cotreatment resulted in the highest glutathione levels and induction of pro-autophagic genes AMPK, HGMB1, ATG5, Beclin 1, and LC3, suppressed the mTOR and BCL2 anti-apoptotic gene. Finally, the docking studies proposed that Amy binds to the active site of the AMPK enzyme, thus inhibiting its activity. This inhibition of AMPK ultimately leads to inhibition of mTOR and thus induces apoptosis in the HepG2 cells. Conclusion Although more in vivo research using animal models is needed to confirm the findings, our findings contribute to the evidence supporting Amy’s potential anticancer effectiveness as an alternative therapeutic option for HCC.

Polydopamine Nanoparticle-Based Combined Chemotherapy and Photothermal Therapy for the Treatment of Liver Cancer

“…HCC development is strictly related to the overexpression of many proteins that play critical roles in hindering the apoptotic cascade, such as Bcl-2, Bcl-xL, and Mcl-1. SRF has been demonstrated to induce apoptosis by downregulating the Bcl-2 family proteins in the HepG2 cells . Another study also demonstrated that the occurrence of nuclear condensation and fragmentation in HepG2 cells is directly related to the dose of administered SRF .…”

Pomelo peel extract induces ROS-mediated DNA double stand break and apoptotic death pathway in Caco-2 colon cancer cells

“…Bcl-2 is for both survival and induced cell death, can lead to cancer growth and prevent cancer treatment. Bax is one member of the B-cell lymphoma (Bcl-2) family, belonging to pro-apoptotic protein and a major pro-apoptotic protein in the Bcl-2 family (El-Sewedy et al, 2023). It is activated by some stimuli from inner cells such as DNA damage, and cytotoxicity.…”

Armeniacae semen amarum: a review on its botany, phytochemistry, pharmacology, clinical application, toxicology and pharmacokinetics

“…These results align with the upregulation of AMPK, HMGB1, beclin-1, and ATG5 mRNA levels, as well as the downregulation of mTOR and Bcl-2 levels. Unlike sorafenib, amygdalin can increase GSH level, reduce MDA level, and exhibit strong DPPH free radical scavenging ability ( El-Sewedy et al, 2023 ). These findings suggest that amygdalin holds significant potential for the treatment of hepatocellular carcinoma.…”